-transparent.png){kind=logo}
The oxidative N-dealkylation of verapamil has been studied in a family of five members with two propositi with an inherited deficiency of trimethylamine N-oxidation (fish-odour syndrome). The results were assessed for possible co-segregation of the trimethylamine N-oxidation phenotype and any observed deficiency in oxidative N-dealkylation. The general pattern of metabolism of verapamil in the five subjects studied was similar to that reported in earlier investigations. Moreover, there were no differences between the two affected subjects and other family members with respect to the metabolic pattern. It is concluded that there is no functional segregation with respect to the mechanisms controlling trimethylamine N-oxidation and verapamil N-dealkylation.
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
January 1990,
Pharmacology & therapeutics,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
February 1987,
Toxicology,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
February 1995,
British journal of clinical pharmacology,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
October 1996,
Pharmacogenetics,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
March 2017,
Molecular microbiology,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
November 1987,
Clinical pharmacology and therapeutics,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
March 2021,
Science advances,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
September 1996,
Xenobiotica; the fate of foreign compounds in biological systems,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
January 1977,
Drug metabolism and disposition: the biological fate of chemicals,
R Ayesh, and
H Kroemer, and
M Eichelbaum, and
R L Smith
January 1971,
The Biochemical journal,
